The Board of Oslo Børs resolved in its meeting on 31 March
to admit the shares in BerGenBio ASA to listing on Oslo
Børs.
The Board stipulated that, prior to the first day of listing
the company must:
- satisfy the requirement for the number of
shareholders as specified in Section 2.4.2 of the Oslo Børs
Listing Rules
- raise at least NOK 200 million in new equity through
its planned share issue
The Board authorised the Chief Executive Officer of Oslo
Børs to fix the date of the first day of listing, which is
to be no later than 15 May 2017.